Bright Minds Biosciences Inc (DRUG)

1.80
+0.15(+9.09%)
  • Volume:
    40,927
  • Bid/Ask:
    1.76/1.81
  • Day's Range:
    1.66 - 1.82

DRUG Overview

Prev. Close
1.65
Day's Range
1.66-1.82
Revenue
-
Open
1.68
52 wk Range
0.9-11
EPS
-1.25
Volume
40,927
Market Cap
29.78M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
63,664
P/E Ratio
-1.67
Beta
1.05
1-Year Change
-79.87%
Shares Outstanding
16,546,661
Next Earnings Date
Nov 30, 2022
What is your sentiment on Bright Minds Biosciences?
or
Market is currently closed. Voting is open during market hours.

Bright Minds Biosciences Inc Analysis

Bright Minds Biosciences Inc Company Profile

Bright Minds Biosciences Inc Company Profile

Employees
0
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA10919W1086
  • CUSIP:10919W108

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyNeutralSellSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell
  • IG➡️trishadónàld_official_fxtrade
    0